Head-To-Head Comparison: Astrana Health (ASTH) and Its Rivals

Astrana Health (NASDAQ:ASTH) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare Astrana Health to similar businesses based on the strength of its institutional ownership, analyst recommendations, profitability, risk, dividends, valuation and earnings.

Profitability

This table compares Astrana Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.36%	11.75%	4.20%
Astrana Health Competitors	-7.92%	-137.33%	-1.29%

Analyst Recommendations

This is a breakdown of current recommendations for Astrana Health and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	2	8	0	2.80
Astrana Health Competitors	1859	7720	13328	820	2.55

Astrana Health currently has a consensus target price of $50.38, indicating a potential upside of 46.01%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.42%. Given Astrana Health’s stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than its competitors.

Insider & Institutional Ownership

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Astrana Health and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Astrana Health	$3.84 billion	$22.49 million	32.24
Astrana Health Competitors	$21.39 billion	$288.54 million	8.11

Astrana Health’s competitors have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Astrana Health has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, Astrana Health’s competitors have a beta of 0.98, indicating that their average share price is 2% less volatile than the S&P 500.

Summary

Astrana Health beats its competitors on 9 of the 13 factors compared.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.